Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort

Jolanta Majcher-Peszynska (1) , Marko Sass (2) , Sora Schipper (2) , Viktor Czaika (3) , Andreas Gussmann (3) , Ralf Lobmann (4) , Ralf G. Mundkowski (1) , Christoph Luebbert (5) , Peter Kujath (6) , Bernhard R. Ruf (7) , Horst Koch (8) , Wolfgang Schareck (2) , Ernst Klar (2) , Bernd Drewelow (1)

1 Institute of Clinical Pharmacology, Centre of Pharmacology and Toxicology
2 Abteilung für Allgemeine, Thorax-, Gefäß- und Transplantationschirurgie, Chirurgische Klinik und Poliklinik
3 Klinik für Gefäßchirurgie
4 Department of Endocrinology, Diabetology and Geriatrics
5 Klinik und Poliklinik für Innere Medizin I
6 Klinik für Chirurgie
7 Innere Medizin 2
8 Oder-Spree Krankenhaus GmbH Beeskow

Mots clés: Pharmacokinetics in diabetes; Tissue penetration; Moxifloxacin; Diabetic foot; Skin and skin structure infection

Jolanta Majcher-Peszynska, Marko Sass, Sora Schipper, Viktor Czaika, Andreas Gussmann, et al.. Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort. European Journal of Clinical Pharmacology, 2010, 67 (2), pp.135-142. ⟨10.1007/s00228-010-0903-5⟩. ⟨hal-00626284⟩